Haybar H - Search Results

1

Cytokines and their role in cardiovascular diseases.

Haybar H, Bandar B, Torfi E, Mohebbi A, Saki N. Haybar H, et al. Cytokine. 2023 Sep;169:156261. doi: 10.1016/j.cyto.2023.156261. Epub 2023 Jul 4. Cytokine. 2023. PMID: 37413877 Review.

2

The Relationship between Salivary Beta-2 Microglobulin and Uremia Intensity in Men with Chronic Renal Failure.

Vahedi M, Malekzadeh H, Haybar H, Soltanian AR, Abdollahzadeh S, Yoosefi H, Seyedian M, Yazdanpanah L, Saeid A, Shabanpour Fooladi M, Ghasemi M. Vahedi M, et al. Among authors: haybar h. Cell J. 2013 Winter;14(4):276-81. Epub 2013 Feb 20. Cell J. 2013. PMID: 23577307 Free PMC article.

3

Cardiovascular Events: A Challenge in JAK2-positive Myeloproliferative Neoplasms.

Haybar H, Khodadi E, Shahjahani M, Saki N. Haybar H, et al. Cardiovasc Hematol Disord Drug Targets. 2017;17(3):161-166. doi: 10.2174/1871529X17666171030122345. Cardiovasc Hematol Disord Drug Targets. 2017. PMID: 29086702 Review.

4

Platelet Activation Polymorphisms in Ischemia.

Haybar H, Khodadi E, Zibara K, Saki N. Haybar H, et al. Cardiovasc Hematol Disord Drug Targets. 2018;18(2):153-161. doi: 10.2174/1871529X18666180326121239. Cardiovasc Hematol Disord Drug Targets. 2018. PMID: 29577867 Review.

5

Mutations and Common Polymorphisms in ADAMTS13 and vWF Genes Responsible for Increasing Risk of Thrombosis.

Haybar H, Khodadi E, Kavianpour M, Saki N. Haybar H, et al. Cardiovasc Hematol Disord Drug Targets. 2018;18(3):176-181. doi: 10.2174/1871529X18666180419102214. Cardiovasc Hematol Disord Drug Targets. 2018. PMID: 29669506 Review.

6

Protective role of heat shock transcription factor 1 in heart failure: A diagnostic approach.

Haybar H, Shahrabi S, Rezaeeyan H, Shirzad R, Saki N. Haybar H, et al. J Cell Physiol. 2019 Jun;234(6):7764-7770. doi: 10.1002/jcp.27639. Epub 2018 Oct 30. J Cell Physiol. 2019. PMID: 30378117 Review.

7

Endothelial Cells: From Dysfunction Mechanism to Pharmacological Effect in Cardiovascular Disease.

Haybar H, Shahrabi S, Rezaeeyan H, Shirzad R, Saki N. Haybar H, et al. Cardiovasc Toxicol. 2019 Feb;19(1):13-22. doi: 10.1007/s12012-018-9493-8. Cardiovasc Toxicol. 2019. PMID: 30506414 Review.

8

T-bet transcription factor in cardiovascular disease: Attenuation or inflammation factor?

Haybar H, Rezaeeyan H, Shahjahani M, Shirzad R, Saki N. Haybar H, et al. J Cell Physiol. 2019 Jun;234(6):7915-7922. doi: 10.1002/jcp.27935. Epub 2018 Dec 7. J Cell Physiol. 2019. PMID: 30536907 Review.

9

Strategies to inhibit arsenic trioxide-induced cardiotoxicity in acute promyelocytic leukemia.

Haybar H, Shahrabi S, Rezaeeyan H, Jodat H, Saki N. Haybar H, et al. J Cell Physiol. 2019 Sep;234(9):14500-14506. doi: 10.1002/jcp.28292. Epub 2019 Feb 15. J Cell Physiol. 2019. PMID: 30770558 Review.

10

Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease.

Haybar H, Shokuhian M, Bagheri M, Davari N, Saki N. Haybar H, et al. J Mol Cell Cardiol. 2019 Jul;132:110-119. doi: 10.1016/j.yjmcc.2019.05.010. Epub 2019 May 15. J Mol Cell Cardiol. 2019. PMID: 31102585 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters